Suchergebnisse - "Loutfy, Mona R"

PubPharm (12)

1

A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection

enthalten in: PloS one | 2015

von Margolick, J. | Apuzzo, L. | Singer, J. | +11

2

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies : final results of two randomised, placebo-controlled trials

enthalten in: The Lancet. Infectious diseases | 2013

von Eron, J. | Cooper, D. | Steigbigel, R. | +116

CommentIn: Lancet Infect Dis. 2013 Jul;13(7):561-2. - PMID 23664332

3

Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy : a randomized controlled trial

enthalten in: AIDS (London, England) | 2012

von Chege, D. | Kovacs, C. | la Porte, C. | +9

4

Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy

enthalten in: HIV clinical trials | 2011

von Loutfy, M. | Brunetta, J. | Kovacs, C. | +7

5

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection : week 96 results of the BENCHMRK 1 and 2 Phase III trials

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2010

von Steigbigel, R. | Cooper, D. | Teppler, H. | +120

6

Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

enthalten in: AIDS care | 2009

von Antoniou, T. | Raboud, J. | Kovacs, C. | +6

7

A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2009

von Gathe, J. | da Silva, B. | Cohen, D. | +8

8

Raltegravir with optimized background therapy for resistant HIV-1 infection

enthalten in: The New England journal of medicine | 2008

von Steigbigel, R. | Cooper, D. | Kumar, P. | +127

CommentIn: N Engl J Med. 2008 Jul 24;359(4):416-8. - PMID 18650518

9

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

enthalten in: The New England journal of medicine | 2008

von Cooper, D. | Steigbigel, R. | Gatell, J. | +127

CommentIn: N Engl J Med. 2008 Jul 24;359(4):416-8. - PMID 18650518

10

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

enthalten in: HIV clinical trials | 2007

von Loutfy, M. | Ackad, N. | Antoniou, T. | +16